by admin | Dec 30, 2025 | News & Opinions
By Cleveland Clinic – Patient with quadruple refractory multiple myeloma achieves complete response with cell therapy A Cleveland Clinic patient participated in a clinical trial of allogenic CAR T-cell therapy to treat highly resistant multiple myeloma and...
by admin | Dec 29, 2025 | News & Opinions
by James Lim, PhD – The Scientist – Let’s face it: Nobody pursues a career in science for the joy of culturing cells. But this thankless and time-intensive task is the backbone of biological research. When it’s done extremely well, the results generated...
by admin | Dec 26, 2025 | News & Opinions
By UCI Health News – CIRM award will support first-of-its-kind clinical trial in humans This award will support a first-in-human safety and tolerability study of an embryonic stem cell-derived neural stem cell product for Huntington’s disease, a milestone for...
by admin | Dec 25, 2025 | News & Opinions
By Mayo Clinic – A Mayo Clinic study published in the September 2025 issue of Science Advances explores a novel approach to retinal gene therapy using fibrin hydrogels encapsulating adeno-associated virus 2-green fluorescent protein (AAV2-GFP). The findings...
by admin | Dec 24, 2025 | News & Opinions
By Heidi Borst – Forbes – Human longevity has reached new heights. During the 20th century, lifespan in high-income countries increased by about 30 years due to public health and medicine advancements, according to a 2024 analysis in Nature Aging.[1] In...
by admin | Dec 23, 2025 | News & Opinions
By Sriparna Roy – Reuters News – Regeneron (REGN.O), opens new tab said on Saturday its experimental cancer combination therapy was effective and showed disappearance of the disease in previously untreated patients with a type of blood cancer in the first...
